<DOC>
	<DOCNO>NCT00597441</DOCNO>
	<brief_summary>The objective trial ass toxicity thymus transplantation follow unrelated umbilical cord blood transplantation . Emphasis place adverse event typically associate umbilical cord blood transplantation . Also , determine whether engraftment third party thymus allograft feasible patient undergone unrelated umbilical cord blood transplantation .</brief_summary>
	<brief_title>Phase I Study Umbilical Cord Blood Transplantation Followed Third Party Thymus Transplantation</brief_title>
	<detailed_description>The objective trial ass toxicity thymus transplantation follow unrelated umbilical cord blood transplantation . Emphasis place adverse event typically associate umbilical cord blood transplantation . Also , determine whether engraftment third party thymus allograft feasible patient undergone unrelated umbilical cord blood transplantation . Thymic engraftment determine biopsy thymus allograft immunohistochemical evidence thymopoiesis . In addition , would like assess thymic function measure number naive T cell number T cell receptor rearrangement excision circle ( TRECS ) , assess diversity T cell receptor beta chain . These data compare age , stem-cell donor source disease match historical control whose stem cell transplant follow thymus transplant . This do descriptive fashion . Other immune parameter follow include T , B , NK cell number , T cell response mitogen , antigen , immunoglobulin production .</detailed_description>
	<criteria>Subjects receive dual cord blood transplant eligible must achieve donor cord blood chimerism &gt; 75 % Tcell myeloid lineage At time thymus transplantation , subject active grade IIIV acute graft versus host disease . At time thymus transplantation , subject must absolute neutrophil count &gt; 500/ul platelet count 50,000/ul ( even achieve via transfusion ) . At time thymus transplantation , subject must &lt; equal 50 circulate CD 34+ cells/ul ( measure within 3 week transplant date ) . At time thymus transplantation , subject great 2 mg/kg/day methylprednisolone equivalent steroid . At time thymus transplantation , PT PTT must less 1.5 time ULN must correctable level . At time thymus transplantation , subject require oxygen pulmonary disease would think make general anesthesia high risk . Subjects must age 18 60 year age . Subjects bone marrow flow cytometry demonstrate residual leukemia Subjects insufficient subcutaneous tissue muscle mass able accept heal thymus transplant , assess surgeon . Prior thymus transplantation , subject evidence active disease HHV6 , West Nile Virus , EBV , CMV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>unrelated</keyword>
	<keyword>umbilical cord blood transplantation</keyword>
	<keyword>thymus transplantation</keyword>
</DOC>